Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Revolution Medicines, Inc.
RVMD
$147.01
Name : Revolution Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $29,133,469,696.00
EPSttm : -5.95
finviz dynamic chart for RVMD
Revolution Medicines, Inc.
$147.01
7.86%
$10.71
RVMD — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

8.95

Margin Of Safety %

Put/Call OI Ratio

1.63

EPS Next Q Diff

-0.03

EPS Last/This Y

-1.66

EPS This/Next Y

0.87

Price

136.31

Target Price

150.16

Analyst Recom

1

Performance Q

14.89

Upside

-252.0%

Beta

1.12

Ticker: RVMD



17 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-17RVMD99.050.910.04133047
2026-03-18RVMD98.070.810.90142010
2026-03-19RVMD99.240.860.52142243
2026-03-20RVMD95.770.864.77142583
2026-03-23RVMD96.531.800.39111130
2026-03-24RVMD95.161.782.23113852
2026-03-25RVMD94.281.783.90114096
2026-03-26RVMD93.571.701.04112544
2026-03-27RVMD92.551.695.58113024
2026-03-30RVMD92.671.6939.32113309
2026-03-31RVMD97.181.771.83117192
2026-04-01RVMD98.651.724.14115532
2026-04-02RVMD99.131.636.57114087
2026-04-06RVMD95.421.643.14115218
2026-04-08RVMD96.771.640.46117286
2026-04-09RVMD96.161.621.16118278
2026-04-13RVMD134.551.631.60129729
DateSymbolLatestP/C OIP/C VolTotal OI
17 items Current Page1 of 1



18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-17RVMD99.05-58.7-196.5-7.60
2026-03-18RVMD98.05-58.7-572.3-7.60
2026-03-19RVMD99.27-58.7-595.5-7.60
2026-03-20RVMD95.78-58.7-529.4-7.60
2026-03-23RVMD96.60-58.7-544.9-7.60
2026-03-24RVMD95.53-58.8-524.6-7.61
2026-03-25RVMD94.28-58.8-500.9-7.61
2026-03-26RVMD93.30-58.8-482.4-7.61
2026-03-27RVMD92.47-58.8-466.7-7.61
2026-03-30RVMD92.71-58.8-471.2-7.61
2026-03-31RVMD97.16-58.8-555.5-7.61
2026-04-01RVMD98.64-58.8-583.6-7.61
2026-04-02RVMD99.20-58.8-594.1-7.61
2026-04-06RVMD95.40-58.8-522.1-7.61
2026-04-07RVMD96.27-58.8-609.7-7.61
2026-04-09RVMD96.22-58.8-537.7-7.61
2026-04-10RVMD96.43-58.8-541.6-7.61
2026-04-13RVMD136.31-58.8-1297.3-7.61
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-17RVMD-1.432.608.19
2026-03-18RVMD-1.432.608.19
2026-03-19RVMD-1.312.608.19
2026-03-20RVMD-1.432.608.19
2026-03-23RVMD-1.432.608.19
2026-03-24RVMD-1.432.608.19
2026-03-25RVMD-1.432.608.39
2026-03-26RVMD-1.432.608.39
2026-03-27RVMD-1.572.608.39
2026-03-30RVMD-1.572.608.39
2026-03-31RVMD-1.572.608.39
2026-04-01RVMD-1.572.608.39
2026-04-02RVMD-1.572.608.39
2026-04-06RVMD-1.572.618.39
2026-04-07RVMD-1.572.618.39
2026-04-08RVMD-1.572.618.39
2026-04-09RVMD-1.572.618.39
2026-04-10RVMD-1.572.618.39
2026-04-13RVMD-1.572.678.95
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-1.86

Avg. EPS Est. Current Quarter

-1.79

Avg. EPS Est. Next Quarter

-1.89

Insider Transactions

-1.57

Institutional Transactions

2.67

Beta

1.12

Average Sales Estimate Current Quarter

3

Average Sales Estimate Next Quarter

18

Fair Value

Quality Score

12

Growth Score

22

Sentiment Score

52

Actual DrawDown %

-9.5

Max Drawdown 5-Year %

-66.1

Target Price

150.16

P/E

Forward P/E

PEG

P/S

P/B

16.46

P/Free Cash Flow

EPS

-5.92

Average EPS Est. Cur. Y​

-7.61

EPS Next Y. (Est.)

-6.74

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

5.8

Return on Equity vs Sector %

-96.7

Return on Equity vs Industry %

-80.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-1297.3
◆ RVMD Healthcare
$136.30
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
0/25
Volume
0/15
Valuation
4/20
TP/AR
8/10
Options
3/10
RSI
84
Range 1M
96.6%
Sup Dist
30.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
9/25
Growth
8/30
Estimates
8/20
Inst/Vol
10/15
Options
1/10
EPS Yr
-31%
EPS NY
18.5%
52W%
98.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +10.2% upside
Quality
3/30
Valuation
4/30
Growth
7/25
Stability
7/10
LT Trend
3/5
Upside
+10.2%
Quality
12
Click a card to see score breakdown Full Analysis →
Revolution Medicines, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 883
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD

Latest News

—
Caricamento notizie per RVMD…
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading